Why did Balaji Amines (BALAMINES) stock move recently?

On 7/27/2026, Balaji Amines moved +5.1% — No clear company-specific catalyst identified in recent credible coverage; the stock rose alongside broader market or sector sentiment ahead of its scheduled board meeting to approve Q1 results. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Balaji Amines (BALAMINES) overvalued or fairly valued?

MarketChacha shows Balaji Amines's valuation in context — a forward P/E of about 21.9, a price-to-book of about 3.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Balaji Amines's revenue?

Balaji Amines reported revenue of ₹1,292 Cr for FY2026, with net profit of ₹165 Cr, per official filings.

What is the share price of Balaji Amines (BALAMINES)?

Balaji Amines last traded at ₹1,991.50 (-3.7% on the day), as of 10/19/2026 — a delayed quote shown for education, not investment advice.

Balaji Amines

BALAMINES · NSE · Chemicals · India

Snapshot

TickerBALAMINES

ExchangeNSE

SectorChemicals

IndustrySpecialty Chemicals

CountryIndia

Employees1,161

HeadquartersHyderabad, India

Websitewww.balajiamines.com

Filings tracked4

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India and internationally. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. It also provides hotels, restaurants, and hospitality services. The company also exports its products to Europe, the United States, and Japan. Balaji Amines Limited was incorporated in 1988 and is headquartered in Hyderabad, India.

Who owns it

Promoters67.6%
Institutions2.5%
Public & other30.0%

18 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 2.1 points over the period — profitability is trending down.

Net margin trend13.8% → 11.7%

Margin has compressed by about 2.1 points over the period — profitability is trending down.

Growth qualityrev -12% · PAT -15%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹2,783 Cr · EPS 90.84

Est. earnings growth +86.9%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹1,425 Cr

Net margin

11.7%

Revenue CAGR (3y)

-15.4%

Profit CAGR (3y)

-19.9%

Net profit (FY2026)

₹167 Cr

Ask MarketChacha about BALAMINES

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 27, 2026
No clear company-specific catalyst identified in recent credible coverage; the stock rose alongside broader market or sector sentiment ahead of its scheduled board meeting to approve Q1 results.
· confidence: low
Jul 24, 2026
No specific company news, earnings, guidance, or filing explains the drop; Balaji Amines shares fell with the broader market or sector.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹1,425 Cr	₹167 Cr	11.7%
FY2025	₹1,397 Cr	₹158 Cr	11.3%
FY2024	₹1,642 Cr	₹205 Cr	12.5%
FY2023	₹2,355 Cr	₹326 Cr	13.8%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹456 Cr	—	—
Q4 FY26	₹395 Cr	—	—
Q3 FY26	₹331 Cr	₹31 Cr	9.5%
Q2 FY26	₹341 Cr	—	—
Q1 FY26	₹358 Cr	—	—

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Credit Rating
Intimation Under Regulation 30 (Listing Obligation and Disclosure Requirements) Regulations, 2015- Withdrawal of Credit Rating.
BSE9/12/2026material
Press Release / Media Release
Press Release in connection with Un- Audited Financial Results of the Company for the Quarter Ended 30th June, 2026
BSE7/27/2026
Board Meeting Outcome for Board Meeting Outcome
Board Meeting Outcome
BSE7/27/2026
Results For The Quarter Ended 30Th June, 2026
Results for the Quarter Ended 30th June, 2026
BSE7/27/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.